journal
https://read.qxmd.com/read/38561012/type-1-diabetes-heterogeneity-in-heritability
#21
JOURNAL ARTICLE
Richard David Leslie
No abstract text is available yet for this article.
March 28, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38561011/familial-aggregation-and-heritability-of-childhood-onset-and-adult-onset-type-1-diabetes-a-swedish-register-based-cohort-study
#22
JOURNAL ARTICLE
Yuxia Wei, Shengxin Liu, Tomas Andersson, Maria Feychting, Ralf Kuja-Halkola, Sofia Carlsson
BACKGROUND: Type 1 diabetes in children is known to be highly heritable, but much less is known about the heritability of adult-onset type 1 diabetes. Thus, our objective was to compare the familial aggregation and heritability of type 1 diabetes in adults and children. METHODS: This Swedish nationwide register-based cohort study included individuals born from Jan 1, 1982, to Dec 31, 2010, identified through the Medical Birth Register who were linked to their parents, full siblings, half siblings, and cousins through the Multi-Generation Register (MGR)...
March 28, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38554713/effects-of-statin-therapy-on-diagnoses-of-new-onset-diabetes-and-worsening-glycaemia-in-large-scale-randomised-blinded-statin-trials-an-individual-participant-data-meta-analysis
#23
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Previous meta-analyses of summary data from randomised controlled trials have shown that statin therapy increases the risk of diabetes, but less is known about the size or timing of this effect, or who is at greatest risk. We aimed to address these gaps in knowledge through analysis of individual participant data from large, long-term, randomised, double-blind trials of statin therapy. METHODS: We conducted a meta-analysis of individual participant data from randomised controlled trials of statin therapy that participated in the CTT Collaboration...
March 26, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38527466/disparities-in-fragility-fracture-and-osteoporosis-care-in-africa
#24
JOURNAL ARTICLE
Kate A Ward, Tafadzwa Madanhire, Kebba Marenah, Lisa K Micklesfield, Celia L Gregson
No abstract text is available yet for this article.
March 22, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38460527/undiagnosed-type-2-diabetes-an-invisible-risk-factor
#25
EDITORIAL
The Lancet Diabetes Endocrinology
No abstract text is available yet for this article.
March 6, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38452781/long-term-trial-outcomes-of-roux-en-y-gastric-bypass-and-one-anastomosis-gastric-bypass-tipping-the-scale
#26
JOURNAL ARTICLE
Paulina Salminen
No abstract text is available yet for this article.
March 4, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38437851/reversibility-of-congenital-hypogonadotropic-hypogonadism-lessons-from-a-rare-disease
#27
JOURNAL ARTICLE
Bradley D Anawalt
No abstract text is available yet for this article.
March 1, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38437850/classes-and-predictors-of-reversal-in-male-patients-with-congenital-hypogonadotropic-hypogonadism-a-cross-sectional-study-of-six-international-referral-centres
#28
JOURNAL ARTICLE
Andrew A Dwyer, Isabella R McDonald, Biagio Cangiano, Luca Giovanelli, Luigi Maione, Leticia F G Silveira, Taneli Raivio, Ana Claudia Latronico, Jacques Young, Richard Quinton, Marco Bonomi, Luca Persani, Stephanie B Seminara, Christopher S Lee
BACKGROUND: Although some male patients with congenital hypogonadotropic hypogonadism (CHH) undergo spontaneous reversal following treatment, predictors of reversal remain elusive. We aimed to assemble the largest cohort of male patients with CHH reversal to date and identify distinct classes of reversal. METHODS: This multicentre cross-sectional study was conducted in six international CHH referral centres in Brazil, Finland, France, Italy, the UK, and the USA...
March 1, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38423025/conceptt-to-care-the-science-of-implementation-in-diabetes-care
#29
JOURNAL ARTICLE
Eleanor M Scott, Helen R Murphy, Karen Kennedy, Partha Kar
No abstract text is available yet for this article.
February 26, 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663950/food-additive-emulsifiers-and-the-risk-of-type-2-diabetes-analysis-of-data-from-the-nutrinet-sant%C3%A3-prospective-cohort-study
#30
JOURNAL ARTICLE
Clara Salame, Guillaume Javaux, Laury Sellem, Emilie Viennois, Fabien Szabo de Edelenyi, Cédric Agaësse, Alexandre De Sa, Inge Huybrechts, Fabrice Pierre, Xavier Coumoul, Chantal Julia, Emmanuelle Kesse-Guyot, Benjamin Allès, Léopold K Fezeu, Serge Hercberg, Mélanie Deschasaux-Tanguy, Emmanuel Cosson, Sopio Tatulashvili, Benoit Chassaing, Bernard Srour, Mathilde Touvier
BACKGROUND: Experimental studies have suggested potential detrimental effects of emulsifiers on gut microbiota, inflammation, and metabolic perturbations. We aimed to investigate the associations between exposures to food additive emulsifiers and the risk of type 2 diabetes in a large prospective cohort of French adults. METHODS: We analysed data from 104 139 adults enrolled in the French NutriNet-Santé prospective cohort study from May 1, 2009, to April 26, 2023; 82 456 (79·2%) were female and the mean age was 42·7 years (SD 14·5)...
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663949/anand-hardikar-a-scientific-nomad-searching-for-the-truth
#31
JOURNAL ARTICLE
Susan Rahimi, Marta Koch
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663948/environmental-chemical-obesogens-what-can-we-do
#32
LETTER
Tim Lobstein
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663947/rethinking-the-label-anti-obesity-medication
#33
LETTER
Stuart W Flint
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663946/vitamin-d-supplements-and-future-fracture-risk-among-mongolian-schoolchildren
#34
LETTER
Ning Ma, Xia Cui, Wenquan Niu
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663945/vitamin-d-supplements-and-future-fracture-risk-among-mongolian-schoolchildren-author-s-reply
#35
LETTER
Adrian R Martineau, Polyna Khudyakov, Davaasambuu Ganmaa
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663944/endpoints-for-clinical-trials-in-type-1-diabetes-drug-development
#36
REVIEW
Alfonso Galderisi, Brynn E Marks, Linda A DiMeglio, Carine de Beaufort
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663943/the-human-insulin-thermal-solution-project-a-private-sector-initiative-to-address-the-thermostability-of-insulin
#37
JOURNAL ARTICLE
Mats Rasmussen, Morten Hach, Jørgen Iwersen, Gayathri Anil, Henrik Rosborg, Jens Larsen, Lise Camilla Hoffmann, Peter Kurtzhals
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38663942/food-additive-emulsifiers-a-new-risk-factor-for-type-2-diabetes
#38
JOURNAL ARTICLE
Mengxi Du, Frank B Hu
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38554714/how-clinically-relevant-is-statin-induced-diabetes
#39
JOURNAL ARTICLE
Hertzel C Gerstein, Marie Pigeyre
No abstract text is available yet for this article.
May 2024: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/38514241/tight-versus-liberal-blood-glucose-control-in-the-intensive-care-unit-special-considerations-for-patients-with-diabetes
#40
REVIEW
Christian von Loeffelholz, Andreas L Birkenfeld
Stress hyperglycaemia, hypoglycaemia, and diabetes are common in critically ill patients and related to clinical endpoints. To avoid complications related to hypoglycaemia and hyperglycaemia, it is recommended to start insulin therapy for the majority of critically ill patients with persistent blood glucose concentrations higher than 10·0 mmol/L (>180 mg/dL), targeting a range of 7·8-10·0 mmol/L (140-180 mg/dL). However, management and evidence-based targets for blood glucose control are under debate, particularly for patients with diabetes...
April 2024: Lancet Diabetes & Endocrinology
journal
journal
47944
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.